5,226
Views
47
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: THORACIC ONCOLOGY

Lung cancer in never-smokers – what are the differences?

, , , &
Pages 931-935 | Received 17 Oct 2016, Accepted 20 Jan 2017, Published online: 17 Feb 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lukas Löfling, Annette Karimi, Fredrik Sandin, Shahram Bahmanyar, Helle Kieler, Mats Lambe, Kristina Lamberg & Gunnar Wagenius. (2019) Clinical characteristics and survival in non-small cell lung cancer patients by smoking history: a population-based cohort study. Acta Oncologica 58:11, pages 1618-1627.
Read now

Articles from other publishers (46)

Cristina Candal-Pedreira, Alberto Ruano-Ravina, Virginia Calvo de Juan, Manuel Cobo, José Manuel Trigo, Enric Carcereny, Marc Cucurull, Rafael López Castro, Eduardo Solís García, Amparo Sánchez-Gastaldo, Bartomeu Massutí, Delvys Rodríguez-Abreu, Anna Estival, María Guirado Risueño, María Pamiés Ramón, Rosario García Campelo, Guillermo Alonso-Jáudenes, Carlos Camps, Edel del Barco Morillo, Clara González Ojea, Manuel Dómine, Alfredo Sanchez-Hernandez, Joaquím Bosch-Barrera, María Ángeles Sala González & Mariano Provencio. (2023) Addressing lung cancer screening eligibility in Spain using 2013 and 2021 USPSTF criteria: cross-sectional study. ERJ Open Research, pages 00468-2023.
Crossref
Mohammad Hamouz, Raneem Y. Hammouz, Muhammad Ahmed Bajwa, Abdelrahman Waleed Alsayed, Magdalena Orzechowska & Andrzej K. Bednarek. (2023) A Functional Genomics Review of Non-Small-Cell Lung Cancer in Never Smokers. International Journal of Molecular Sciences 24:17, pages 13314.
Crossref
Nikki M Carroll, Andrea N Burnett-Hartman, Katharine A Rendle, Christine M Neslund-Dudas, Robert T Greenlee, Stacey A Honda, Anil Vachani & Debra P Ritzwoller. (2023) Smoking status and the association between patient-level factors and survival among lung cancer patients. JNCI: Journal of the National Cancer Institute 115:8, pages 937-948.
Crossref
Sam Khan, Nathaniel Hatton, Daniel Tough, Robert C. Rintoul, Coral Pepper, Lynn Calman, Fiona McDonald, Clare Harris, Amelia Randle, Michelle C. Turner, Ruth A. Haley, Janette Rawlinson, Philip A. J. Crosbie, Frank McCaughan & Matthew Hatton. (2023) Lung cancer in never smokers (LCINS): development of a UK national research strategy. BJC Reports 1:1.
Crossref
Yuan-Yuan Zhou, Xiao-Jun Sun, Jun-Quan Liu & Ling-Li Xiang. (2023) Identification of a novel survival predictor, CSF2RB, for female lung cancer in never smokers (LCNS) by a bioinformatics analysis. Medicine 102:23, pages e34019.
Crossref
Zhanshu Ma, Qi Gao, Wenjing Xin, Lei Wang, Yan Chen, Chang Su, Songyan Gao & Ruiling Sun. (2023) The role of miR-143-3p/FNDC1 axis on the progression of non-small cell lung cancer. European Journal of Histochemistry 67:2.
Crossref
Javier Simarro, Gema Pérez-Simó, Nuria Mancheño, Emilio Ansotegui, Carlos Francisco Muñoz-Núñez, José Gómez-Codina, Óscar Juan & Sarai Palanca. (2023) Impact of Molecular Testing Using Next-Generation Sequencing in the Clinical Management of Patients with Non-Small Cell Lung Cancer in a Public Healthcare Hospital. Cancers 15:6, pages 1705.
Crossref
Namita Pandey, Jonita Chongtham, Soumyadip Pal, Ashraf Ali, Sanjeev Lalwani, Deepali Jain, Anant Mohan & Tapasya Srivastava. (2023) When “No-Smoking” is not enough: Hypoxia and nicotine acetylcholine receptor signaling may drive lung adenocarcinoma progression in never-smokers. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1870:2, pages 119302.
Crossref
Choy-Lye Chei, Norie Sawada, Nikhil K. Khankari, Motoki Iwasaki, Taiki Yamaji, Hui Cai, Taichi Shimazu, Manami Inoue, Xiao-Ou Shu, Wei Zheng & Shoichiro Tsugane. (2022) Isoflavone and soy food intake and risk of lung cancer in never smokers: report from prospective studies in Japan and China. European Journal of Nutrition 62:1, pages 125-137.
Crossref
Anna Andrzejczak, Anna Partyka, Andrzej Wiśniewski, Irena Porębska, Konrad Pawełczyk, Kuba Ptaszkowski, Piotr Kuśnierczyk, Monika Jasek & Lidia Karabon. (2023) The association of BTLA gene polymorphisms with non-small lung cancer risk in smokers and never-smokers. Frontiers in Immunology 13.
Crossref
Bright Huo, Daria Manos, Zhaolin Xu, Kara Matheson, Samuel Chun, John Fris, Alison M.R. Wallace & Daniel G. French. (2023) Screening Criteria Evaluation for Expansion in Pulmonary Neoplasias (SCREEN). Seminars in Thoracic and Cardiovascular Surgery 35:4, pages 769-780.
Crossref
Namrata Balhara, Mamta Devi, Ajay Balda, Manisha Phour & Arup Giri. (2023) Urine; a new promising biological fluid to act as a non-invasive biomarker for different human diseases. URINE 5, pages 40-52.
Crossref
Hamza Abrar Mughal, Mette T Mouritzen, Zsuzsanna Takacs-Szabó & Weronika Maria Szejniuk. (2022) Treatment of induced oligometastatic disease after partial response to immunochemotherapy in patient with stage IV non-small cell lung cancer and severe toxicity. BMJ Case Reports 15:12, pages e252590.
Crossref
Erping Long, Harsh Patel, Jinyoung Byun, Christopher I Amos & Jiyeon Choi. (2022) Functional studies of lung cancer GWAS beyond association. Human Molecular Genetics 31:R1, pages R22-R36.
Crossref
Shoshana Adler, Rowena Yip, Huiwen Chan, Qiang Cai, Yeqing Zhu, Natthaya Triphuridet, Andrew Kaufman, Emanuela Taioli, Raja Flores, Claudia I. Henschke & David F. Yankelevitz. (2022) Comparison of lung cancer aggressiveness in patients who never smoked compared to those who smoked. Lung Cancer 171, pages 90-96.
Crossref
Miriam Möller, Juliane Adner, Wolfgang Schütte & Marcus Krüger. (2022) 30- und 90-Tage-Letalität bei Patienten mit Lungenkarzinom im Stadium IV in Abhängigkeit der Primärtherapie. TumorDiagnostik & Therapie 43:05, pages 321-330.
Crossref
Moawia Mohammed Ali Elhassan, Ahmed Abdalla Mohamedani, Sahar Abdelrahman Hamid Mohamed, Anas Osman Ahmed Hamdoun, Dafalla Omer Abuidris, Alsideeg Mohammed Alamin Mohammed & Khalid Dafaallah Awadelkarim. (2022) Lung Cancer in Sudan. Journal of Thoracic Oncology 17:4, pages 489-498.
Crossref
Gerard N. Olive, Henry M. Marshall, Ian A. Yang, Rayleen V. Bowman & Kwun M. Fong. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine 621 633 .
Jorge Ataucuri-Vargas, Ahmed Hussein & Humberto K. Choi. 2022. Lung Health and the Exposome. Lung Health and the Exposome 125 147 .
Lu Wang, Lei Tang, Tengfei Ge, Feng Zhu, Dan Liu, Hua Guo, Peng Qian & Ning Xu. (2021) LncRNA DLGAP1-AS2 regulates miR-503/cyclin D1 to promote cell proliferation in non-small cell lung cancer. BMC Pulmonary Medicine 21:1.
Crossref
Sara Nejatinamini, Jenny Godley, Leia M Minaker, Tolulope T Sajobi, Gavin R McCormack, Martin J Cooke, Candace I J Nykiforuk, Lawrence de Koning & Dana Lee Olstad. (2021) Quantifying the contribution of modifiable risk factors to socio-economic inequities in cancer morbidity and mortality: a nationally representative population-based cohort study. International Journal of Epidemiology 50:5, pages 1498-1511.
Crossref
Danielle Mazza, Xiaoping Lin, Fiona M. Walter, Jane M. Young, David J. Barnes, Paul L. Mitchell, Bianca Brijnath, Andrew Martin, Kenneth J. O'Byrne & Jon D. Emery. (2021) Do ethnic patients report longer lung cancer intervals than Anglo‐Australian patients?: Findings from a prospective, observational cohort study. European Journal of Cancer Care 30:6.
Crossref
Maisam Makarem, Doreen A. Ezeife, Adam C. Smith, Janice J. N. Li, Jennifer H. Law, Ming-Sound Tsao & Natasha B. Leighl. (2021) Reflex ROS1 IHC Screening with FISH Confirmation for Advanced Non-Small Cell Lung Cancer—A Cost-Efficient Strategy in a Public Healthcare System. Current Oncology 28:5, pages 3268-3279.
Crossref
Serdar Karakurt, Sureyya Erturk, Irem Sobaci, Irem Bereket, Sadik Seker & Gamze Polat. (2021) Investigation of structural differences of silica, silver and iron nanoparticles on the proliferation of human lung cancer. Pharmacy & Pharmacology International Journal 9:4, pages 137-141.
Crossref
Miriam Moeller, Juliane Adner, Wolfgang Schuette & Marcus Krueger. (2021) 30- und 90-Tage-Letalität bei Patienten mit Lungenkarzinom im Stadium IV in Abhängigkeit der Primärtherapie. Pneumologie.
Crossref
Tong Lu, Tong Qiu, Bin Han, Yuanyong Wang, Xiao Sun, Yi Qin, Ao Liu, Nan Ge & Wenjie Jiao. (2020) Circular RNA circCSNK1G3 induces HOXA10 signaling and promotes the growth and metastasis of lung adenocarcinoma cells through hsa-miR-143-3p sponging. Cellular Oncology 44:2, pages 297-310.
Crossref
Elvin S. Cheng, Sam Egger, Suzanne Hughes, Marianne Weber, Julia Steinberg, Bayzidur Rahman, Heather Worth, Alberto Ruano-Ravina, Patrick Rawstorne & Xue Qin Yu. (2021) Systematic review and meta-analysis of residential radon and lung cancer in never-smokers. European Respiratory Review 30:159, pages 200230.
Crossref
Ziyuan Shen, Chenlu He, Haimiao Chen, Lishun Xiao, Yingliang Jin & Shuiping Huang. (2020) Potential Genes Associated with the Survival of Lung Adenocarcinoma Were Identified by Methylation. Computational and Mathematical Methods in Medicine 2020, pages 1-13.
Crossref
Lina Ang, Cheryl Pui Yi Chan, Wai-Ping Yau & Wei Jie Seow. (2020) Association between family history of lung cancer and lung cancer risk: a systematic review and meta-analysis. Lung Cancer 148, pages 129-137.
Crossref
E. Giroux Leprieur, A. Vergnenègre & J. Trédaniel. (2020) Épidémiologie des cancers du poumon en France : les tendances actuelles. Revue des Maladies Respiratoires Actualités 12:2, pages 2S6-2S13.
Crossref
Raneem Y. Hammouz, Joanna K. Kostanek, Aleksandra Dudzisz, Piotr Witas, Magdalena Orzechowska & Andrzej K. Bednarek. (2020) Differential expression of lung adenocarcinoma transcriptome with signature of tobacco exposure. Journal of Applied Genetics 61:3, pages 421-437.
Crossref
James M. Clark, David T. Cooke, David L. Chin, Garth H. Utter, Lisa M. Brown & Miriam Nuño. (2020) Does one size fit all? An evaluation of the 2018 Leapfrog Group minimal hospital and surgeon volume thresholds for lung surgery. The Journal of Thoracic and Cardiovascular Surgery 159:5, pages 2071-2079.e2.
Crossref
Anant Mohan, Avneet Garg, Aditi Gupta, Satyaranjan Sahu, Chandrashekhar Choudhari, Vishal Vashistha, Ashraf Ansari, Rambha Pandey, AshuSeith Bhalla, Karan Madan, Vijay Hadda, Hariharan Iyer, Deepali Jain, Rakesh Kumar, Saurabh Mittal, Pawan Tiwari, RavindraM Pandey & Randeep Guleria. (2020) Clinical profile of lung cancer in North India: A 10-year analysis of 1862 patients from a tertiary care center. Lung India 37:3, pages 190.
Crossref
Sufei Wang, Pei Ma, Guanzhou Ma, Zhilei Lv, Feng Wu, Mengfei Guo, Yumei Li, Qi Tan, Siwei Song, E. Zhou, Wei Geng, Yanran Duan, Yan Li & Yang Jin. (2020) Value of serum tumor markers for predicting EGFR mutations and positive ALK expression in 1089 Chinese non-small-cell lung cancer patients: A retrospective analysis. European Journal of Cancer 124, pages 1-14.
Crossref
Dyda Dao, Jennifer M. O’Connor, Aminah Jatoi, Jennifer Ridgeway, Erin Deering, Anna Schwecke, Carmen Radecki Breitkopf, Olivia Huston & Jennifer G. Le-Rademacher. (2019) A qualitative study of healthcare-related experiences of non-smoking women with lung cancer. Supportive Care in Cancer 28:1, pages 123-130.
Crossref
A. Vergnenègre, J. Trédaniel, L. Bigay-Gamé, O. Bylicki, J-C. Pairon, T. Urban & M. Colonna. (2019) Épidémiologie des cancers du poumon en France: les tendances actuelles. Revue des Maladies Respiratoires Actualités 11:3, pages 169-176.
Crossref
Elisa Chilet-Rosell, Lucy A. Parker, Ildefonso Hernández-Aguado, María Pastor-Valero, José Vilar, Isabel González-Álvarez, José María Salinas-Serrano, Fermina Lorente-Fernández, M. Luisa Domingo & Blanca Lumbreras. (2019) The determinants of lung cancer after detecting a solitary pulmonary nodule are different in men and women, for both chest radiograph and CT. PLOS ONE 14:9, pages e0221134.
Crossref
Amanda J.W. Gibson, Haocheng Li, Adrijana D’Silva, Anifat A. Elegbede, Roxana A. Tudor, Shannon Otsuka, D. Gwyn Bebb & Winson Y. Cheung. (2019) Factors associated with early mortality in non-small cell lung cancer patients following systemic anti-cancer therapy: A 10 year population-based study. Lung Cancer 134, pages 141-146.
Crossref
Marya Ghazipura, Eric Garshick & Kevin Cromar. (2019) Ambient PM 2.5 exposure and risk of lung cancer incidence in North America and Europe . Environmental Research Communications 1:1, pages 015004.
Crossref
Young-Chul Kim & Young-Joo Won. (2019) The Development of the Korean Lung Cancer Registry (KALC-R). Tuberculosis and Respiratory Diseases 82:2, pages 91.
Crossref
Amanda J.W. Gibson, Haocheng Li, Adrijana D’Silva, Roxana A. Tudor, Anifat A. Elegbede, Shannon Otsuka, Dafydd Gwyn Bebb & Winson Y. Cheung. (2019) Comparison of Clinical Characteristics and Outcomes in Relapsed Versus De Novo Metastatic Non–Small Cell Lung Cancer. American Journal of Clinical Oncology 42:1, pages 75-81.
Crossref
Chundi Gao, Jing Zhuang, Huayao Li, Cun Liu, Chao Zhou, Lijuan Liu & Changgang Sun. (2018) Exploration of methylation-driven genes for monitoring and prognosis of patients with lung adenocarcinoma. Cancer Cell International 18:1.
Crossref
Niels Lyhne Christensen, Anders Løkke, Susanne Oksbjerg Dalton, Jane Christensen & Torben Riis Rasmussen. (2018) Smoking, alcohol, and nutritional status in relation to one-year mortality in Danish stage I lung cancer patients. Lung Cancer 124, pages 40-44.
Crossref
Ildikó Fritz & Håkan Olsson. (2017) Lung cancer in young women in southern Sweden: A descriptive study. The Clinical Respiratory Journal 12:4, pages 1565-1571.
Crossref
Edward B. Stelow & Hadi Yaziji. (2018) Immunohistochemistry, carcinomas of unknown primary, and incidence rates. Seminars in Diagnostic Pathology 35:2, pages 143-152.
Crossref
María Torres-Durán, Alberto Ruano-Ravina, Karl T. Kelsey, Isaura Parente-Lamelas, Virginia Leiro-Fernández, Ihab Abdulkader, Mariano Provencio, José Abal-Arca, Olalla Castro-Añón, Carmen Montero-Martínez, Iria Vidal-García, Margarita Amenedo, Antonio Golpe-Gómez, Cristina Martínez, Rosirys Guzmán-Taveras, María José Mejuto-Martí, Alberto Fernández-Villar & Juan Miguel Barros-Dios. (2017) Environmental tobacco smoke exposure and EGFR and ALK alterations in never smokers' lung cancer. Results from the LCRINS study. Cancer Letters 411, pages 130-135.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.